Reversal of chemoresistance and enhancement of apoptosis by statins through down-regulation of the NF-κB pathway

This publication has 27 references indexed in Scilit:

• Embelin, an Inhibitor of X Chromosome-Linked Inhibitor-of-Apoptosis Protein, Blocks Nuclear Factor-κB (NF-κB) Signaling Pathway Leading to Suppression of NF-κB-Regulated Antiapoptotic and Metastatic Gene Products
  Molecular Pharmacology, 2007
• Statin Drugs and Risk of Advanced Prostate Cancer
  JNCI Journal of the National Cancer Institute, 2006
• Drug Insight: statins and gastrointestinal cancer
  Nature Clinical Practice Gastroenterology & Hepatology, 2006
• Transcription Factor NF‐κB: A Sensor for Smoke and Stress Signals
  Annals of the New York Academy of Sciences, 2005
• Oral Silibinin Inhibits Lung Tumor Growth in Athymic Nude Mice and Forms a Novel Chemocombination with Doxorubicin Targeting Nuclear Factor κB–Mediated Inducible Chemoresistance
  Clinical Cancer Research, 2004
• Statins differ in their ability to block NF-kB activation in human blood monocytes
  Int. Journal of Clinical Pharmacology and Therapeutics, 2003
• Nuclear transcription factor-κB as a target for cancer drug development
  Leukemia, 2002
• HMG-CoA reductase inhibitors and the malignant cell: the statin family of drugs as triggers of tumor-specific apoptosis
  Leukemia, 2002
• Diverse effects of inhibition of 3-hydroxy-3-methylglutaryl-CoA reductase on the expression of VCAM-1 and E-selectin in endothelial cells
  Biochemical Journal, 2001
• Paclitaxel sensitivity of breast cancer cells with constitutively active NF-κB is enhanced by IκBα super-repressor and parthenolide
  Oncogene, 2000